(R)-3-(4-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperazin-1-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid

Catalog No. :
ACHNNA592
CAS No. :
2044709-92-2
Molecular Formula :
C27H33N3O6
Molecular Weight :
495.58

IUPAC Name:(R)-3-(4-(((9H-fluoren-9-yl)methoxy)carbonyl)piperazin-1-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid

(R)-3-(4-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperazin-1-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-(4-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperazin-1-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid
IUPAC Name(R)-3-(4-(((9H-fluoren-9-yl)methoxy)carbonyl)piperazin-1-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid
Molecular FormulaC27H33N3O6
Molecular Weight495.58
SMILESO=C(O)[C@H](NC(OC(C)(C)C)=O)CN1CCN(C(OCC2C3=C(C4=C2C=CC=C4)C=CC=C3)=O)CC1
InChI KeyWURNFZDTXMOKNM-HSZRJFAPSA-N
Synonym1-Piperazinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-4-[(9H-fluoren-9-ylmethoxy)carbonyl]-, (αR)-;(R)-3-(4-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperazin-1-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid;(2R)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperazin-1-yl)propanoic acid
CAS No.2044709-92-2

Synthetic Route by SureRoute

1. ACHNNA592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHNNA592 route product structure diagram
    ACHNNA5922044709-92-2
Inquiry

2. ACHNNA592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHNNA592 route product structure diagram
    ACHNNA5922044709-92-2
Inquiry

Comments (0)